Bausch Health Companies - BHC Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last year. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" BHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BHC, but not buy additional shares or sell existing shares.
View BHC analyst ratings or view top-rated stocks.

4 analysts have issued twelve-month price targets for Bausch Health Companies' stock. Their BHC share price forecasts range from $6.00 to $15.00. On average, they anticipate the company's share price to reach $10.60 in the next year. This suggests a possible upside of 46.6% from the stock's current price.
View analysts price targets for BHC or view top-rated stocks among Wall Street analysts.

Bausch Health Companies' stock was trading at $6.28 at the beginning of the year. Since then, BHC stock has increased by 15.1% and is now trading at $7.23.
View the best growth stocks for 2023 here.

Bausch Health Companies saw a increase in short interest in February. As of February 28th, there was short interest totaling 27,480,000 shares, an increase of 15.8% from the February 13th total of 23,740,000 shares. Based on an average trading volume of 5,710,000 shares, the short-interest ratio is presently 4.8 days. Approximately 7.7% of the shares of the stock are short sold.
View Bausch Health Companies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 9th 2023.
View our BHC earnings forecast.

Bausch Health Companies Inc. (NYSE:BHC) issued its earnings results on Monday, August, 2nd. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.95 by $0.02. The business earned $2.10 billion during the quarter, compared to the consensus estimate of $2.12 billion. Bausch Health Companies had a positive trailing twelve-month return on equity of 553.04% and a negative net margin of 2.77%.

Bausch Health Companies updated its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.45 billion-$4.60 billion, compared to the consensus revenue estimate of $8.31 billion.

43 employees have rated Bausch Health Companies Chief Executive Officer Joseph C. Papa on Glassdoor.com. Joseph C. Papa has an approval rating of 97% among the company's employees. This puts Joseph C. Papa in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Gilead Sciences (GILD), Micron Technology (MU), Constellation Software (CSU), Intact Financial (IFC), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Advanced Micro Devices (AMD) and Bank of America (BAC).

Bausch Health Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "BHC."

Bausch Health Companies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Goldentree Asset Management LP (5.88%), Franklin Resources Inc. (4.89%), Natixis (4.37%), National Bank of Canada FI (3.63%), Laurion Capital Management LP (2.88%) and Lombard Odier Asset Management USA Corp (0.00%). Insiders that own company stock include Amy B Wechsler, Christina Ackermann, Holdings LP Valueact, John Paulson, Joseph F Gordon, Robert Spurr, Russell Barrans, Sam Eldessouky, Schutter Richard U De, Seana Carson, Steven D Miller and William D Humphries.
View institutional ownership trends.

Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of BHC stock can currently be purchased for approximately $7.23.

Bausch Health Companies (NYSE:BHC) has a market capitalization of $2.62 billion and generates $8.12 billion in revenue each year. The company earns $-225,000,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis.

The company employs 19,900 workers across the globe.

Bausch Health Companies' mailing address is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. The official website for the company is www.bauschhealth.com. The company can be reached via phone at (514) 744-6792, via email at ir@bauschhealth.com, or via fax at 514-744-6272.